The Effect of Diathermy Therapy on Isolated Lumbar Extension (ILEX) Training

NCT06852872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-10-03

No results posted yet for this study

Summary

To evaluate the effectiveness of the Isolated Back Extension (ILEX) machine Myosom and examine the influence of preheating on resistance training, the investigators will recruit a cohort of 14 healthy individuals, including both male and female participants, who have no prior experience with ILEX training, for a 9-week training program consisting of a total of 18 sessions. Baseline (BL) measurements will be conducted in the week before the initiation of training, and two follow-up measurements (F/U 1 and F/U 2) carried out after the ninth and eighteenth sessions, with a minimum break of 48 hours after the last training session to ensure proper recovery and to prevent inaccuracies in muscle thickness measurement arising due to acute oedema.

Conditions

  • Resistance Training
  • Healthy Participants Study

Interventions

OTHER

CRET Therapy

Diathermy therapy with a protocol to preheat the back extensor muscle

OTHER

ILEX training

Isolated lumbar Extension Training

OTHER

CRET therapy sham

Diathermy therapy withouth any radiofrequency as a sham intervention

Sponsors & Collaborators

  • University of Applied Sciences and Arts of Southern Switzerland

    lead OTHER

Principal Investigators

  • Ron Clijsen, PhD · University of Applied Sciences and Arts of Southern Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-29
Primary Completion
2025-04-15
Completion
2025-04-15

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06852872 on ClinicalTrials.gov